Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07360405 · ClinicalTrials.gov registry record · NA
Dietary Intervention for Migraine Relief
A NA study, sponsored by American University.
- Not yet
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT07360405 is a NA study that has not yet begun recruiting, run by American University. The registered enrollment target is 40 participants.
The verdict
NCT07360405, a NA study, has not yet begun recruiting, sponsored by American University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to evaluate whether a low-glutamate diet can improve migraine symptoms in adults with migraine and to explore possible biological changes associated with dietary improvement. The study focuses on whether reducing dietary glutamate intake may influence processes involved in migraine, such as brain excitation, inflammation, and oxidative stress. The main questions this study aims to answer are: Does following a low-glutamate diet reduce the number of migraine days and the severity and duration of migraine attacks, and improve quality of life? Are improvements in migraine symptoms associated with changes in blood-based biological markers related to migraine activity? Researchers will compare participants assigned to the low-glutamate diet with participants assigned to a wait-list control group to evaluate differences in migraine outcomes and related biological measures. Participants will: Complete a baseline run-in period while tracking headaches using a daily migraine diary Either follow a low-glutamate dietary intervention or continue their usual diet as part of a wait-list control Complete standardized questionnaires related to migraine symptoms and quality of life Provide blood samples for laboratory analyses Undergo neuroimaging assessments (for a subset of participants)
Interventions
- BEHAVIORAL Dietary training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2026-01 |
| Est. Completion | 2027-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07360405
The ClinicalTrials.gov registry entry for NCT07360405 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is American University, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dietary training is the first listed.
NCT07360405 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07360405 about?
NCT07360405 is a clinical study titled "Dietary Intervention for Migraine Relief". The goal of this clinical trial is to evaluate whether a low-glutamate diet can improve migraine symptoms in adults with migraine and to explore possible biological changes associated with dietary improvement. The study focuses on whether reducing dietary glutamate intake may influence processes inv...
What is the current status of trial NCT07360405?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2026-01. Estimated completion is 2027-03.
What interventions are being tested in trial NCT07360405?
The interventions under investigation include: Dietary training (BEHAVIORAL).
Who is sponsoring clinical trial NCT07360405?
This trial is sponsored by American University, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.